摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[Ti(η5-C5Me4SiMe2NMe(CH2)3-κ-NMe)Cl2] | 1293997-59-7

中文名称
——
中文别名
——
英文名称
[Ti(η5-C5Me4SiMe2NMe(CH2)3-κ-NMe)Cl2]
英文别名
3-[[dimethyl-(2,3,4,5-tetramethylcyclopenta-2,4-dien-1-yl)silyl]-methylamino]propyl-methylazanide;titanium(4+);dichloride
[Ti(η5-C5Me4SiMe2NMe(CH2)3-κ-NMe)Cl2]化学式
CAS
1293997-59-7
化学式
C16H30Cl2N2SiTi
mdl
——
分子量
397.299
InChiKey
WPDRJUKLGAVJAB-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.62
  • 重原子数:
    22
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    4.2
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    (1-(chlorodimethylsilyl)-2,3,4,5-tetramethylcyclopentadienyl)titanium trichlorideN,N'-二甲基-1,3-丙二胺甲苯 为溶剂, 以87%的产率得到[Ti(η5-C5Me4SiMe2NMe(CH2)3-κ-NMe)Cl2]
    参考文献:
    名称:
    Reactions of [Ti(η5-C5Me4SiMe2Cl)Cl3] with Diamines, a Suitable Approach to Prepare Mono- and Dinuclear Cyclopentadienyl-silyl-amido Titanium Complexes with Constrained and Unstrained Structures
    摘要:
    Complex [Ti(eta(5)-C5Me4SiMe2Cl)Cl-3] (1) reacts with NH2(CH2)(n)NH2 (n = 3, 4), under appropriate reaction conditions, to yield the corresponding di- and mononuclear constrained-geometry cydopentadienyl-silyl-amido complexes [Ti{eta(5)-C5Me4SiMe2-kappa-N(CH2)(n/2)}Cl2-](2) (n = 3, 2a; 4, 2b) and [Ti{eta(5)-C5Me4SiMe2-kappa-N(CH2)(n)NH2}Cl-2] (n = 3, 3a; 4, 3b). Complexes 2a and 2b are obtained as pure compounds when the reaction is carried out in a 1(Ti):1.5(diamine) molar ratio, while the derivatives 3 cannot be selectively prepared. Treatment of 1 with NH2(CH2)(5)NH2 gives the dinuclear derivative [Ti{eta(5)-C5Me4SiMe2-kappa-N(CH2)(2.5)-}Cl-2](2) (2c) as a single complex, regardless of the reaction stoichiometry. On monitoring these reactions by NMR spectroscopy, the formation of the transient asymmetrical dinuclear complexes [TiCl2{eta(5)-C5Me4SiMe2-kappa-N(CH2)(n)NH-eta(5)-C5Me4SiMe2}TiCl3] (n = 3, 4a; 4, 4b; 5, 4c) is observed. The analogue dinuclear complex [TiCl2{eta(5)-C5Me4SiMe2-kappa-N(CH2)(3)NMe-eta(5)-C5Me4SiMe2}TiCl3] (6) is synthesized, on a preparative scale, by treatment of 1 with an equimolar amount of N-methylpropylenediamine, which is transformed into the mononuclear derivative [Ti{eta(5)-C5Me4SiMe2-kappa-N(CH2)(3)NHMe}Cl-2] (7) upon addition of a further equivalent of the diamine. However, treatment of 1 with 1 equiv of N-methylpropylenediamine proceeds with the formation of the mononuclear constrained-geometry compound [Ti{eta(5)-CsMe4SiMe2-kappa-N(CH2)(3)NHMe center dot HCl}Cl-2] (5). The reaction of 1 with 2 equiv of NH2(CH2)(3)NMe2 or NHMe(CH2)(3)NMe2 specifically affords, respectively, a mononuclear cyclopentadienyl-silyl-amido derivative with constrained geometry, [Ti{eta(5)-C5Me4SiMe2-kappa-N(CH2)(3)NMe2}Cl-2] (8), or unconstrained geometry, [Ti{eta 5-C5Me4SiMe2NMe(CH2)(3)-kappa-NMe}Cl-2] (9). When the reaction with NHMe(CH2)(3)NHMe is monitored by NMR spectroscopy, the mononuclear intermediate [Ti{eta(5)-C5Me4SiMe2NMe(CH2)(3)NHMe}Cl-3] (11) and the dinuclear complex [Ti{eta(5)-C5Me4SiMe2NMe(CH2)(1.5)-}Cl-3](2) (12) are observed. The dinuclear complex [Ti{eta(5)-C5Me4SiMe2NMe(CH2)(3)-} Cl-3](2) (13) is synthesized by treatment of 1 with 1 equiv of NHMe(CH2)(6)NHMe. All the reported compounds were characterized
    DOI:
    10.1021/om200101k
点击查看最新优质反应信息

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)